profound 2017 · 2018. 9. 5. · profound best in class • 1st and only patented device (mgh) with...
TRANSCRIPT
Profound 2017
Profound 2017
• Market Overview
• Product Overview
• Clinical Overview
• Before/After Pictures
MARKET OVERVIEW
The Problem: Skin Begins to Sag As People Age
The Problem
Collagen levels
decrease as we
age.
Our bodies stop
producing elastin
when we are in
our 20’s.
So our skin
begins to sag.
Profound Face – Areas of Treatment
Most Common Facial Concerns for Women
1 Syneron on-line consumer survey, 2015 Syneron Proprietary and Confidential
28%
25%
21%
14%
7% 6%
Double chin Sagging skin injawline/jowls
Turkey neck Wrinkles in thecheek area
Loss of volumein cheeks
Other
Profound Market Summary
• Profound Face– Jawline
– Jowls
– Submentum
– Neck
• Profound Body– Cellulite
– Abdomen
– Arms
– Knees
PRODUCT OVERVIEW
First FDA Indication for Use
Profound is indicated for use in dermatologic
and general surgical procedures for
electrocoagulation and hemostasis, and the
percutaneous treatment of facial wrinkles.
Second FDA Indication for Use
Profound is indicated for use when using the
SubQ Handpiece and Cartridge to improve the
appearance of cellulite in patients with
Fitzpatrick Skin Types I-III, as supported by long-
term data (6 Months)
Patent Protection
SYNERON ANNOUNCES STRENGTHENING OF PATENT PROTECTION
FOR THE PROFOUND™ SYSTEM
New Patent Allowances from USPTO Enhance Intellectual Property Covering
the Profound Micro-Needle Technology
Yokneam, Israel, November 8, 2016 — Syneron Medical Ltd. (NASDAQ:
ELOS), a leading global aesthetic device company, announced today that the
United States Patent and Trademark Office (USPTO) has allowed new claims
to a key patent covering the micro-needle technology used in the Company’s
Profound™ system. The new allowances expand the patent claims to cover
any device that uses a module to control and deliver radiofrequency (RF)
energy through an array of needles to deliver energy into the dermal layer of
skin to induce fractional damage for the purpose of collagen generation. The
patent is owned by Massachusetts General Hospital (MGH) and Syneron
holds an exclusive worldwide license to the patent for use in aesthetic
applications. In addition to this patent, Syneron holds several additional U.S.
and international patents covering the Profound system.
Profound Best in Class
• 1st and Only Patented Device (MGH) with Temperature-
Controlled RF clinically proven to create Elastin, Collagen, and
Hyaluronic Acid.
• Customized Treatments:
– Dermal Handpiece – 1.5mm in Dermis for optimal volume addition of new
elastin, hyaluronic acid, collagen. skin tightening
– SubQ Handpiece – 2.9mm to 5.8mm in Adipose Tissue for volume
reduction and tissue remodeling.
• 100% response rate: 1 treatment. 1 hour.
• Unique Real Time Feedback: Optimal Partial De-Naturing of
Collagen at 67 Degrees for 3 Seconds measured 10 times a
second. (Alexiades Arch Derm 2010 - Beckman Laser Institute)
Applicator - Proprietary Design for Optimal Treatment
• 5 pairs of electrically-isolated 32 gauge needles
• 6 mm length; insulated; specially beveled to maintain sharpness
• Fractionated zones of thermal injury created in and limited to the deep dermis (1-2 mm deep into the skin)
Profound Best in Class
Profound Best in Class
Profound System
• Bi-polar RF energy delivery system
• Micro-needle RF energy delivery
▪ Real Time Temperature Controlled RF
▪ Specific Temperature Endpoints
▪ Real Time impedance feedback from
tissue
• Console
▪ Color touch screen
▪ Intuitive GUI
• Ergonomic handpiece
▪ Single button
• Single use cartridge per patient
Applicator & Cartridge
applicator
cartridge
electrodes
cold plate
Treatment Screen
1 sec 3sec 5 sec
1 sec 3 sec 5 sec
Precise Control Over Thermal Endpoints of Treatment
• 96% of the energy is absorbed in the dermal layer
• Thermal profile confined along and between needles
• Temperature controlled lesion created
• Precise fractionated zone of
thermal injury
• Temperature readings every 1/10
of a second
• Adjusts temperature based on
Real Time feedback to maintain
optimal treatment
Precise Temperature Control – 10 Times/Second
• A specific target temperature is reached regardless of skin condition
• Energy is adjusted to reach and maintain target temperature
Impedance
Power Temperature
Optimal Parameters For Treatment (Alexiades/Aksan/MGH/Nelson/Beckman Laser Institute)
Figure 1 - Thermal dose for collagen. The blue curve indicates the dose necessary to start collagen denaturation, while the red curve indicates when the denaturation process is fully completed.
Partially denatured collagen is more effective at triggering
a strong wound healing response
67°C, 4 sec
Tissue Volume – Clinical Efficacy
Invasiveness
No
n-
Inva
sive
Min
Inva
sive
Inva
sive
Profound
Face-lifting Surgery
Efficacy
ilooda
Sublative, Pixel RF,Endymed,
Viora,Venus Viva, Invasix
Fractora, etc.
Neck TiteCannula based
technology
Micro-needling with no thermal feedback
Surgical procedures
Different RF technologies
US Technology
Mono-polarRF technology
Competitive Products
Profound Specifications
Bi-polar Radio Frequency 460 +/- 5kHz
Maximum Output Voltage 84 VRMS. 5 W per channel
Channels 5 independent bi-polar channels
Mode PID temperature control
Target Temperature Range 65-75 degrees C (149 – 167 degrees F) +/- 1 degree C
Treatment Duration 3.5 seconds. 0.2 second increments
User Interface GUI – color touch screen
System Dimensions 125 x 46.5 x 44.5 centimeters29.5 x 18.5 x 17.5 inches
System Weight 23 kg. / 55 lbs.
Electrical Requirements 100-240 VAC, 2.5 A, 50-60 Hz, single phase
Focal edema following heating.
Minimally invasive 32g needles
Profound Treatment
CLINICAL OVERVIEW
PEER REVIEWED ARTICLES
Summaries of 8 Peer Reviewed Articles
“The healing process of Profound was shown to produce a profoundincrease in collagen and elastin content.”
(DERM SURG 2010)
Prospective Multicenter Clinical Trial of a Minimally Invasive
Temperature-Controlled Bipolar Fractional Radiofrequency
System for Rhytid and Laxity Treatment
Alexiades M, et al. Dermatology Surg. 2013;39(2):263-73.
STUDY DETAILS
• 100 subjects at 7 centers
• Single pass fractional RF (FRF) treatment (temp. 62 to
78°C, 3-5 sec energy, impedance restriction 200 -
3,000 Ohms)
• 5 physicians - blinded assessment of photos
• Wrinkles and skin laxity assessment. 4 treatment zones(all subjects treated in gray area)
RESULTS AT 6 MONTHS AFTER TREATMENT
• 100% response rate with average of 26% improvement in wrinkles
(Fitzpatrick Wrinkle Scale)
• 95% of patients showed improvement in skin laxity (Alexiades scale)
• >90% of patients were satisfied or very satisfied
• Precise intradermal real-time temperature control - minimal side
effects only.
Blinded, Randomized, Quantitative Grading Comparison of
Minimally Invasive, Fractional Radiofrequency and Surgical
Face-lift to Treat Skin Laxity
Alexiades M, et al. Arch Dermatology. 2010 Apr;146(4):396-405.
STUDY DETAILS
• 15 subjects with facial skin laxity
• Single pass fractional RF (FRF) treatment
(temp. 62 to 78°C, 3-5 sec energy, impedance
300 - 2,000 Ohms)
• 5 evaluators - blinded assessment of photos
compared with 6 sets of surgical face-lifts.
Preselected target temperatures (eg, 70ºC)
are maintained for a desired duration (eg, 5
seconds); parameters are selected for optimal
collagen denaturation.
RESULTS
• Average laxity improvement was 37% of surgical face-lift
• Patient satisfaction was high
• Transient side effects with return to normal activities within 24 hours
• Surgical face-lift group experienced scarring and other side effects with
7-10 days downtime.
Elastometry and Clinical Results After Bipolar Radiofrequency
Treatment of Skin
Willey A, Kilmer S, Newman J, et al. Dermatology Surg. 2010 Jun;36(6):877-
84.
STUDY DETAILS
• 44 patients (41 females, 3 males)
• 1 Fractional RF (FRF) treatment session to thermal
zones on lower part of face
• Elasticity measurements
• Blinded physician assessment of photos.
RESULTS AT 6 MONTHS AFTER TREATMENT
• 100% of patients showed improvement in wrinkles
(Fitzpatrick Wrinkle Scale)
• 98% of patients showed improvement in skin laxity (Alexiades scale)
• 96% of patients reported ‘moderate to dramatic’ benefit
• Significant improvement in elasticity (3 months).
Treated area (in gray)
5 measurement sites (circles)
Bipolar fractional radiofrequency treatment induces
neoelastogenesis and neocollagenesis
Hantash BM, et al. Lasers Surge Med. 2009;41(1):1-9.
STUDY DETAILS
• 22 subjects treated by FRF
• Treated immediately, 2 days, 14 days, 28 days,
or 10 weeks prior to pre-scheduled abdominoplasty
• Dermal tissue temperature maintained at
72°C for 4 sec
• Wound healing response was studied.Long-term dermal remodeling and
neocollagenesis post-FRF treatment. RESULTS
• Histology showed zones of denatured collagen within the reticular
dermis with zones of spared dermis up to 28 days post-treatment
• New dermal tissue by 10 weeks
• Dermal volume, hyaluronic acid, and elastin content increased
• Vigorous wound healing + active dermal remodeling process.
2 Review Papers:
Noninvasive radio frequency for skin tightening and body contouring.
Weiss RA. Semin Cutan Med Surg. 2013 Mar;32(1):9-17.
There is a demand for noninvasive methods for skin tightening,
wrinkle reduction & body contouring.
• Fractional bipolar RF is a newer non-ablative approach
• An array of micro-needles delivers bipolar RF energy to specific
depths in tissue
• Fractionated zones of thermal damage to deep dermal collagen
• Induce wound healing, dermal remodeling and new collagen,
elastin, and hyaluronic acid formation
• Achieve desired cosmetic results for wrinkle reduction, tissue tightening, and
body contouring.
Lolis MS, Goldberg DJ. Dermatology Surg. 2012 Nov;38(11):1765-76.
Radiofrequency in cosmetic dermatology.
Pilot clinical study of a novel minimally invasive bipolar
microneedle radiofrequency device
Hantash BM, et al. Lasers Surg Med. 2009;41(2):87-95.
STUDY DETAILS
• 15 subjects
• Treated with 5 pairs of 35 W bipolar electrode tips
• Maximum power delivered at beginning and
then reduced to maintain target temperature
• Range of pulse durations (1 - 25 sec)
• Lesion temperatures between 60-80°C.Lesion size is dependent on treatment time.
Undamaged zones after 1 sec of treatment at 70°C.RESULTS
• Histology showed zones of denatured collagen within the reticular
dermis with sparing of adnexal structures and adipose tissue
• Controlled creation of zones of thermal damage in the dermis
• Varying pulse length allowed for fractional sparing of dermal tissue.
A predictive model of minimally invasive bipolar fractional
radiofrequency skin treatment
Berube D, Renton B, Hantash BM. Lasers Surg Med. 2009;41(7):473-8.
STUDY DETAILS
• Develop a model for optimal treatment parameters
• The model incorporated temperature feedback,
selectable target dermal temperatures & an
epidermal cooling plate
• Areas of thermal injury were validated with In vivo
histology. Model geometry
RESULTS
• Lesion size predicted by the model matched histology samples
• Heating confined to both ends of the electrodes
• 96% of the power was deposited in the dermis without spreading to
nearby skin layers.
Profound Histology
Fractional Lesions in Deep Dermis
NOTE: Dermal sparing between lesions
Zone of Sparing
New Dermal Tissue Created
Profound amount of new elastin and collagen observed at
10 weeks post Profound treatment
Elastin Deposition
New Collagen
Old Collagen
Full Dermal StructureOld Collagen
Mixed
New Collagen
New Hyaluronic Acid
1. New dermal volume
2. Collagen, hyaluronic acid, and
elastin content profoundly
increased
3. Unique wound healing response
BEFORE / AFTER PICTURES
PROFOUND FACE
3 months post 1 treatment
Courtesy
Suzanne Kilmer M.D., Andrea Willey, M.D.
Before
Profound Face
Before
6 months
2 years later
Before
Results still visible 2 years after
Profound treatment
Profound Face – Long Term Results
Profound Face
Before 3 months post 1 treatment
Courtesy Suzanne Kilmer M.D.
/ Andrea Willey, M.D.
Significant tightening in neck area
Better defined jaw line
Improved wrinkles
Profound Face
Before 3 months post 1 treatment
Courtesy James Newman, MDSignificant tightening in neck area
Fuller and tighter appearance
Profound Face
Profound Face
6 months post 1 treatment
Courtesy Macrene Alexiades M.D.
Before
1.67 mm
Baseline
3 Month Follow up
Calculated degree of elevation
Contour change greatest at site noted clinically
4 mm
3.5 mm
3.0 mm
2.5 mm
2.0 mm
1.5 mm
1.0 mm
0.5 mm
0 mm
-0.5 mm
-1.0 mm
Profound Volume - Treatment Results
Before Post 2 months
Profound Face
Courtesy Stephen Eubanks, MD
4 Months Post 1 Treatment
Profound Face
Before
Profound Face
Courtesy Ben Talei, MD
Before 3 Months After
Profound Face
Courtesy Ben Talei, MD
Before 6 Months After
Profound Face
Courtesy Julene Samuels, MD
Before 6 Weeks After 6 Months After
Profound Face
Courtesy Julene Samuels, MD
Before 1 Month After
Profound Neck
Courtesy Stephen Bloch, MD
Before 3 Months After
Profound Neck
Courtesy Andrew Kornstein, MD
Before 6 Months After
Profound Neck
Profound Neck
Profound Neck
Profound Neck
Profound Body
Profound Body
Profound Body
Courtesy Christine Gould, MD
Before 6 Weeks After
Dermal & Sub Q HP
Profound Body
Courtesy Andrew Kornstein, MD
Before 4 Months After Dermal HP
Physician Testimonials
Physician Testimonials
Real Patient Testimonials about Profound Treatments
Profound Diary
Day 1 Day 2
Profound Diary
Day 3 Day 4
Profound Diary
Day 5 Day 6
Profound Diary
Before/90 Days AfterCourtesy Ben Talei, MD
Profound Diary
Before/90 Days AfterCourtesy of Ben Talei, MD